The C-terminal portion of the Hrs protein interacts with Tsg101 and interferes with human immunodeficiency virus type 1 Gag particle production.
about
Gliadin peptide P31-43 localises to endocytic vesicles and interferes with their maturationCrystallographic and Functional Analysis of the ESCRT-I /HIV-1 Gag PTAP InteractionThe ubiquitin-proteasome system in spongiform degenerative disordersExploring the functional interaction between POSH and ALIX and the relevance to HIV-1 release.The nucleocapsid region of HIV-1 Gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral buddingMutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation.Gliadin peptides as triggers of the proliferative and stress/innate immune response of the celiac small intestinal mucosa.Mycobacterium tuberculosis type VII secreted effector EsxH targets host ESCRT to impair traffickingThe role of cellular factors in promoting HIV budding.Chromatin modifying protein 1A (Chmp1A) of the endosomal sorting complex required for transport (ESCRT)-III family activates ataxia telangiectasia mutated (ATM) for PanC-1 cell growth inhibition.Distal leucines are key functional determinants of Alix-binding simian immunodeficiency virus SIV(smE543) and SIV(mac239) type 3 L domains.The Dual Role of an ESCRT-0 Component HGS in HBV Transcription and Naked Capsid Secretion.HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus ReleaseSimian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.How ubiquitin functions with ESCRTsDifferential control of CXCR4 and CD4 downregulation by HIV-1 Gag.Hrs inhibits citron kinase-mediated HIV-1 budding via its FYVE domain.Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.
P2860
Q27321328-813213FC-C188-488D-B951-4304900FF41CQ27665841-A884BE77-4420-4D6E-AF1E-73EB63DEAB76Q28386906-A7584C0E-BAB4-4AAC-B79C-F6FC68AFE798Q30157284-E3DB0766-7588-4A88-9DFA-BCB5D29072C6Q33417652-96E2D376-1468-4489-A29C-273BCD2CED20Q33450556-4CA7FB0B-AABC-43DD-A413-448AB8385355Q33815533-59F2D7CA-455E-4442-A0E5-953C9DE83E64Q34447313-3D39F726-8E0D-4983-8DE8-0EA41E5E6027Q35034264-1CE7035F-1B0A-4A43-84C7-6B1181D824EEQ35113746-436E8C52-071F-4F1B-8CA3-3474962277A3Q35232569-0AEE5A15-FD12-408E-8842-DB68468267ECQ35362891-A94B06FF-A7CB-4EDB-B696-F537E931566CQ35797289-8E2B75A6-8001-4679-849C-23ECDBEB2A64Q36138149-9FAD271E-0574-417E-8626-8DC58195A5C9Q37469794-7431368F-F539-4C64-8E60-3B26E9019004Q37896711-C3C54341-1169-4B65-AD74-83CAC9443D99Q40014256-FDED742A-D942-4B64-A2F9-F53010829F6DQ40285743-F92D4B86-A257-4ECF-90C0-3CDD14E63170Q47555946-D6DF6C6B-BE54-40F3-ACCA-4B0983B66BA8
P2860
The C-terminal portion of the Hrs protein interacts with Tsg101 and interferes with human immunodeficiency virus type 1 Gag particle production.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The C-terminal portion of the ...... ype 1 Gag particle production.
@ast
The C-terminal portion of the ...... ype 1 Gag particle production.
@en
type
label
The C-terminal portion of the ...... ype 1 Gag particle production.
@ast
The C-terminal portion of the ...... ype 1 Gag particle production.
@en
prefLabel
The C-terminal portion of the ...... ype 1 Gag particle production.
@ast
The C-terminal portion of the ...... ype 1 Gag particle production.
@en
P2093
P2860
P356
P1433
P1476
The C-terminal portion of the ...... ype 1 Gag particle production.
@en
P2093
Brian R Houck-Loomis
Fadila Bouamr
Marc C Johnson
Martha De Los Santos
Rebecca J Casaday
Stephen P Goff
P2860
P304
P356
10.1128/JVI.01413-06
P407
P577
2006-12-20T00:00:00Z